Search

All phases Early Phase 1 Phase 1 Phase 2 Phase 3 Phase 4 Phase 1/2 Phase 2/3

All statuses Open (recruiting or opening soon) Active, not recruiting Completed

25 miles 50 miles 100 miles 200 miles

Newest Nearest Most relevant

Apply Reset

How to Get Started: Identifying the Critical Ingredients to Improve Gait Initiation in Parkinson Disease

Trial N/A Completed Sept. 19, 2024

Deep Brain Stimulation of the Cuneiform Nucleus for Levodopa-resistant Freezing of Gait in Parkinson's Disease

Trial N/A Completed Sept. 18, 2024

A Clinical Study of NLY01 in Patient's With Early Parkinson's Disease

Trial Phase 2 Completed Sept. 18, 2024

Neurodegenerative Diseases Progression Markers (MARKERS-NDD)

Trial N/A Recruiting Sept. 18, 2024

ADDIA Proof-of-Performance Clinical Study

Trial N/A Completed Sept. 18, 2024

Dual-task Augmented Reality Treatment for Parkinson's Disease

Trial Phase 2 Completed Sept. 18, 2024

Relative Bioavailability and Food Effect Study of CVN424

Trial Phase 1 Completed Sept. 18, 2024

A Study to Investigate The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7486967 in Participants With Early Idiopathic Parkinson's Disease.

Trial Phase 1 Completed Sept. 18, 2024

Cognitive Training in Parkinson Study

Trial N/A Completed Sept. 18, 2024

Motor Learning-based Clinical Pilates Rehabilitation Protocol for Patients with Parkinson's Disease

Trial N/A Completed Sept. 18, 2024

Biomarkers to Guide Directional DBS for Parkinson's Disease

Trial N/A Completed Sept. 18, 2024

Factors Associated with Falling in Parkinson's Disease

Trial N/A Completed Sept. 18, 2024

Role of Nasal Dysbiosis in Parkinson Disease

Trial N/A Completed Sept. 18, 2024

Visual Perturbation Training to Reduce Fall Risk in People with Parkinson's Disease

Trial N/A Completed Sept. 18, 2024

Vibrotactile Coordinated Reset (vCR) for the Treatment of Advanced Parkinson's Disease Patients Who Have Previously Received vCR Stimulation

Trial N/A Not yet recruiting Sept. 4, 2024

Longitudinal Analysis of Gait Variability to Predict Falls in Parkinson's Disease

Trial N/A Terminated Sept. 4, 2024

The Efficacy of Repetitive Transcranial Magnetic Stimulation in Parkinson's Disease：A Randomized, Double-blind, Multicenter, Placebo-controlled Trial

Trial N/A Not yet recruiting Sept. 3, 2024

iDAP Injection in the Treatment of Parkinson's Disease

Trial Early Phase 1 Not yet recruiting Sept. 3, 2024

Comparison of Balance, Activity-specific Balance Confidence and Quality of Life in Parkinson's Patients

Trial N/A Completed Sept. 2, 2024

NeuroGlove PD Study Clinical

Trial Early Phase 1 Completed Sept. 2, 2024